BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 11187747)

  • 1. [Recent trends in male reproductive disorders].
    Iwamoto T; Nozawa S
    Nihon Rinsho; 2000 Dec; 58(12):2514-20. PubMed ID: 11187747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional differences and temporal trends in male reproductive health disorders: semen quality may be a sensitive marker of environmental exposures.
    Nordkap L; Joensen UN; Blomberg Jensen M; Jørgensen N
    Mol Cell Endocrinol; 2012 May; 355(2):221-30. PubMed ID: 22138051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testicular dysgenesis syndrome: possible role of endocrine disrupters.
    Bay K; Asklund C; Skakkebaek NE; Andersson AM
    Best Pract Res Clin Endocrinol Metab; 2006 Mar; 20(1):77-90. PubMed ID: 16522521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cryptorchidism and hypospadias as a sign of testicular dysgenesis syndrome (TDS): environmental connection.
    Toppari J; Virtanen HE; Main KM; Skakkebaek NE
    Birth Defects Res A Clin Mol Teratol; 2010 Oct; 88(10):910-9. PubMed ID: 20865786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of exposure to endocrine disrupters in utero and in childhood on adult reproduction.
    Norgil Damgaard I; Main KM; Toppari J; Skakkebaek NE
    Best Pract Res Clin Endocrinol Metab; 2002 Jun; 16(2):289-309. PubMed ID: 12064894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible effects of endocrine disruptors on male reproductive function.
    Mori C
    Kaibogaku Zasshi; 2001 Aug; 76(4):361-8. PubMed ID: 11577437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What is new in cryptorchidism and hypospadias--a critical review on the testicular dysgenesis hypothesis.
    Thorup J; McLachlan R; Cortes D; Nation TR; Balic A; Southwell BR; Hutson JM
    J Pediatr Surg; 2010 Oct; 45(10):2074-86. PubMed ID: 20920735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in male reproductive health and effects of endocrine disruptors in Scandinavian countries.
    Toppari J; Haavisto AM; Alanen M
    Cad Saude Publica; 2002; 18(2):413-20. PubMed ID: 11923882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testicular dysgenesis syndrome and the development and occurrence of male reproductive disorders.
    Virtanen HE; Rajpert-De Meyts E; Main KM; Skakkebaek NE; Toppari J
    Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):501-5. PubMed ID: 16005920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. International geographic correlation study of the prevalence of disorders of male reproductive health.
    Serrano T; Chevrier C; Multigner L; Cordier S; Jégou B
    Hum Reprod; 2013 Jul; 28(7):1974-86. PubMed ID: 23670171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical correlates of environmental endocrine disruptors.
    Safe S
    Trends Endocrinol Metab; 2005; 16(4):139-44. PubMed ID: 15860409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Environmental factors in genitourinary development.
    Yiee JH; Baskin LS
    J Urol; 2010 Jul; 184(1):34-41. PubMed ID: 20478588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testicular dysgenesis syndrome.
    Skakkebaek NE
    Horm Res; 2003; 60 Suppl 3():49. PubMed ID: 14671395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reproductive dysgenesis in wildlife: a comparative view.
    Edwards TM; Moore BC; Guillette LJ
    Int J Androl; 2006 Feb; 29(1):109-21. PubMed ID: 16466531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do environmental estrogens contribute to the decline in male reproductive health?
    Jensen TK; Toppari J; Keiding N; Skakkebaek NE
    Clin Chem; 1995 Dec; 41(12 Pt 2):1896-901. PubMed ID: 7497651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biology and epidemiology of testicular dysgenesis syndrome.
    Asklund C; Jørgensen N; Kold Jensen T; Skakkebaek NE
    BJU Int; 2004 May; 93 Suppl 3():6-11. PubMed ID: 15086436
    [No Abstract]   [Full Text] [Related]  

  • 17. Cryptorchidism as part of the testicular dysgenesis syndrome: the environmental connection.
    Main KM; Skakkebaek NE; Toppari J
    Endocr Dev; 2009; 14():167-73. PubMed ID: 19293583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of estrogens on the development of the testis during fetal and neonatal life].
    Habert R; Delbes G; Duquenne C; Livera G; Levacher C
    Gynecol Obstet Fertil; 2006 Oct; 34(10):970-7. PubMed ID: 16971153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocrine Disrupting Chemicals and Reproductive Health in Boys and Men.
    Rodprasert W; Toppari J; Virtanen HE
    Front Endocrinol (Lausanne); 2021; 12():706532. PubMed ID: 34690925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Negative impact of endocrine-disrupting compounds on human reproductive health.
    Balabanič D; Rupnik M; Klemenčič AK
    Reprod Fertil Dev; 2011; 23(3):403-16. PubMed ID: 21426858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.